ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
82.765
0.00%
Bitcoin
63,643.55
1.20%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. SMAIO SA (ALSMA) Quote

SMAIO SA

SMAIO SA (ALSMA)

EU
3.42
-0.08
(-2.29%)
Closed May 04 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
3.42
Bid
3.16
Ask
3.50
Volume
701
3.42 Day's Range 3.44
1.90 52 Week Range 3.98
Market Cap
17.882M
Previous Close
3.50
Open
3.44
Last Trade
140
@
3.42
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,015
Shares Outstanding
5,228,651
Dividend Yield
-
PE Ratio
6.28
Earnings Per Share (EPS)
0.54
Revenue
2.48M
Net Profit
2.85M

About SMAIO SA

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.smaio.com
Headquarters
Saint-priest, Rhone, Fra
Founded
1970
SMAIO SA is listed in the Surgical,med Instr,apparatus sector of the Euronext with ticker ALSMA. The last closing price for SMAIO was 3.50 €. Over the last year, SMAIO shares have traded in a share price range of 1.90 € to 3.98 €.

SMAIO currently has 5,228,651 shares outstanding. The market capitalization of SMAIO is 17.88 € million. SMAIO has a price to earnings ratio (PE ratio) of 6.28.

ALSMA Latest News

More News

SMAIO : INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL

(Article L.233-8-II du Code de Commerce et Article 223-16 du règlement général de l’AMF) Regulatory News: Dénomination sociale de l’émetteur : SMAIO (Paris:ALSMA)     Adresse du siège social : 2...

May 02 2024
Business Wire

SMAIO : Mise à disposition du rapport financier annuel 2023

Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, Code ISIN : FR0014005I80 / Mnémonique : ALSMA, éligible PEA-PME) (Paris:ALSMA), un...

April 29 2024
Business Wire

SMAIO publie ses résultats annuels 2023

Résultat net positif à 1,1 M€ en comptes sociaux (-0,8 M€ en consolidé*), attestant d’une bonne maîtrise des coûts dans un contexte de croissance et d’investissement dans les technologies de...

April 16 2024
Business Wire

SMAIO : Chiffre d’affaires 2023 en hausse de +120% à 5,4 M€

Forte progression du chiffre d’affaires portée par le paiement d’étape de 3 M$ (~2,8 M€) de NuVasive au cours du 1er semestre 2023 Accélération des ventes du système Kheiron au 4ème trimestre...

January 23 2024
Business Wire

SMAIO : Bilan semestriel du Contrat de Liquidité contracté avec TP ICAP

Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, Code ISIN : FR0014005I80 / Mnémonique : ALSMA, éligible PEA-PME) (Paris:ALSMA), un...

January 09 2024
Business Wire

SMAIO: Success of a New Educational Program in the United States Designed to Promote SMAIO Technology in the World's Leading Spine Market

Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA), a French player specialized in complex spine...

November 21 2023
Business Wire

SMAIO : Agenda financier 2024

Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris Code ISIN : FR0014005I80 / Mnémonique : ALSMA, éligible PEA-PME) (Paris:ALSMA), un...

November 09 2023
Business Wire

SMAIO publie ses résultats semestriels 2023

Chiffre d’affaires SMAIO du 1er semestre 2023 à 4,0 M€, hors opérations intra-groupe1, en hausse soutenue de +203% grâce au paiement d’étape de 3 M$ (~2,8 M€) de NuVasive Poursuite de...

October 18 2023
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.257.886435331233.173.53.0811033.38760544DE
40.3210.32258064523.13.53.063643.290759DE
120.5619.58041958042.863.62.5810153.16744573DE
261.0644.91525423732.363.62.2811222.96354163DE
520.3812.53.043.981.922482.82999977DE
156-2.33-40.52173913045.755.751.914033.13574574DE
260-2.33-40.52173913045.755.751.914033.13574574DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
oldstocks oldstocks 4 minutes ago
The point was they jump in on moving stocks with volume. JAGX already had the volume and moving.
They added to the volume buying and then the selling and shorting. And repeating

Over the last year JAGX was on alerts a few times.
JAGX
ChannelTrader ChannelTrader 4 minutes ago
NIH - Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662103/

Purpose
M
surfer44 surfer44 5 minutes ago
You're welcome. I was looking for something with thunder in it and I remembered Thunderclap Newman. Turned out to be a nice song...
nowwhat2 nowwhat2 5 minutes ago
Wow, hey.......One of those charts there forced me to take a fresh look......

This one ;
https://investorshub.advfn.com/uimage/uploads/2024/5/4/ezfdrbtc_555_4_capt_6m_BASIC_FRESH_LOOK.jpg


I thought ; "Wait a minute - Hey man - Why, that looks somewhat "I
BTCUSD
Acme Investments Acme Investments 5 minutes ago
Websites are overrated and also costly!! I'd pocket the change!!
WNBD
Shekiboy Shekiboy 5 minutes ago
Discuss what?

Announcements are just that. Nothing more.

That's the OTC.

Where's the flippin proof???


Come on bro.
SPZI
RIOgrande44 RIOgrande44 6 minutes ago
Going through the archives, I found this. Great post and it still tends to be trending that way and still rings true. Dk has taken zero steps to take us private. He has taken several steps to get us trading again. A phone call to HQ confirms this and business is doing well. Waiting on the next ch
kickedoffagain kickedoffagain 7 minutes ago
It's a disaster of an "upgrade".
LBSR
ChannelTrader ChannelTrader 9 minutes ago
That's outrageous.
Doctors Ordered To Euthanize MILLIONS of Vaxxed to Cover-Up ‘Disturbing’ Side Effects

Big Pharma and the medical industry are desperately scrambling to cover up the full extent of the human tragedy caused by the Covid mRNA vaccines, according to an industry w
PutzMueler PutzMueler 9 minutes ago
Bullish Engulfing Candle We get the Last-trading-day

https://stockcharts.com/h-sc/ui?s=NB.TO

6 month, daily, Candlestick
https://money.tmx.com/advanced-chart/NB

https://school.stockcharts.com/doku.php?id=chart_analysis:candlestick_bullish_reversal_
NB
baerga baerga 9 minutes ago
ALLR could be close to FDA stamp of approval? https://x.com/DeepBlueEquity/status/1786672362181509361 DD by DeepBlueEquity several posts
ALLR
ChannelTrader ChannelTrader 10 minutes ago
I believe we will suffer more pandemic attacks.
Are you ready for the next pandemic?
bbotcs bbotcs 11 minutes ago
lj: NVDA
AC is a very sore subject with me at the moment.
NVDA
DewDiligence DewDiligence 12 minutes ago
It's a matter of degree. Announcing advancement of the MariTide program to phase-3 without additional comment would have less impact on the phase-2 trial integrity than the gushing endorsement of efficacy AMGN conveyed on the CC.
AMGN
baerga baerga 12 minutes ago
$ALLR already getting a lot of eyes this weekend Twitter DD https://x.com/DeepBlueEquity/status/1786681105329820131 here
ALLR
TradingCharts TradingCharts 13 minutes ago
9-minute mark👂️
Emilie talks brine.

https://www.purelithium.io/blog/global-lithium-podcast/
Episode 154 - Emilie Bodoin is the CEO of Pure Lithium
IBATF
skitahoe skitahoe 14 minutes ago
I don't know if anyone knew the size of the trade, anyone see it?

Gary
NWBO
TRUSTUNITS1000000 TRUSTUNITS1000000 14 minutes ago
Wonder about this company
DCMDF
TRUSTUNITS1000000 TRUSTUNITS1000000 14 minutes ago
Neat company
DCMDF
TRUSTUNITS1000000 TRUSTUNITS1000000 14 minutes ago
Wonder if fka
DCMDF
TRUSTUNITS1000000 TRUSTUNITS1000000 15 minutes ago
Share structure great
DCMDF
Tiger Money Tiger Money 15 minutes ago
Well written and thank you for sharing. I couldn’t agree more. I think you are on to something. LG hates shareholders, especially the ones inherited like us/me!

Fundamentally, don’t CEOs not have an obligation to his/her shareholders? I don’t get it. I thought he had a fiduciar
AGSS
TRUSTUNITS1000000 TRUSTUNITS1000000 15 minutes ago
Down u.s,
DCMDF
TRUSTUNITS1000000 TRUSTUNITS1000000 15 minutes ago
Interesting company
DCMDF

Your Recent History

EU
ALSMA
SMAIO
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved